Economic TimesLean R·
Kiran Mazumdar-Shaw flags pharma's risk aversion
New Delhi: Indian pharmaceutical industry's aversion to taking risks poses a major hurdle for innovation and that needs to change with the use of technology, according to Biocon chairperson Kiran Mazumdar-Shaw."In pharma and biopharma, the pipeline is the lifeline," Mazumdar-Shaw said at a meeting on quality management in New Delhi last week, stressing the need to replenish the drug development pipeline continuously.Drug discovery is fraught with risks, with only one or two out of 10 candidates…
Read at Economic Times →
